- Absence seizures
- Adrenocorticotrophic hormone
- Atonic seizures
- Autism spectrum disorder
- Benign familial infantile seizures-5 (BFIS5)
- Cannibidiol (CBD)
- Carbamazepine
- Clobazam
- Corticosteroids
- Developmental and epileptic encephalopathy (DEE)
- Dravet syndrome
- Early Infantile Epileptic Encephalopathy type 13 (EIEE13) (Ohtahara Syndrome)
- Electroencephalogram (EEG)
- Epilepsy
- Febrile seizures
- Focal seizures
- GABA Agents (GABAergic drugs)
- GABAergic drugs
- Gain of function or GOF
- Gametes
- Genetic mosaicism
- Infantile-onset seizures (West Syndrome)
- Infantile or epileptic spasms (West Syndrome)
- Lacosamide
- Lamotrigine
- Lennox-Gastaut Syndrome
- Levetiracetam
- Loss of Function or LOF
- Magnetic resonance imaging (MRI)
- Missense variants
- Myoclonic seizures
- NaV1.6 channel
- Oxcarbazepine
- Paroxysmal dyskinesia
- Pathogenic SCN8A
- phenotypic spectrum
- Phenytoin
- Refractory seizures
- Rufinamide
- SCN8A gene variants (mutations)
- Sodium channel
- Sodium channel blockers (SCBs)
- Sudden unexplained death in epilepsy (SUDEP).
- Tonic-clonic seizures
- Tonic seizures
- Topiramate
- Valproate
- West Syndrome
- Whole exome sequencing (WES)
- Zonisamide